The following presentation topic will be presented at the Hematologic Malignancy Grand Rounds Conference on Friday, December 13, 2013 from 9:15 a.m. - 10:15 a.m. in M224 Markee Classroom, Second Floor, Green Zone, Duke South Clinic's Davison Building.
" Treatment of Older Patients with High Risk Myelodysplastic Syndrome:
A New Clinical Trial Option"
by Mitchell Horwitz, MD
Disclosure: Mitchell Horwitz, MD - Consultant for Gamida cell, PI for Sanofi-Aventis, and Advisory Board Member for Spectrum.